WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004096216) USE OF A TOPICAL MEDICAMENT COMPRISING RILUZOLE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/096216    International Application No.:    PCT/EP2004/004478
Publication Date: 11.11.2004 International Filing Date: 28.04.2004
IPC:
A61K 31/428 (2006.01), A61K 45/06 (2006.01)
Applicants: BIOFRONTERA PHARMACEUTICALS GMBH [DE/DE]; Hemmelrather Weg 201, 51377 Leverkusen (DE) (For All Designated States Except US).
SYCH, Michael [DE/DE]; (DE) (For US Only).
GOPPELT, Andreas [DE/DE]; (DE) (For US Only)
Inventors: SYCH, Michael; (DE).
GOPPELT, Andreas; (DE)
Agent: ZWICKER, Jörk; Boehmert & Boehmert, Hollerallee 32, 28209 Bremen (DE)
Priority Data:
03009559.0 28.04.2003 EP
60/471,882 20.05.2003 US
Title (EN) USE OF A TOPICAL MEDICAMENT COMPRISING RILUZOLE
(FR) UTILISATION DE RILUZOLE DANS LE TRAITEMENT DE MALADIES CARACTERISEES PAR L'HYPERPROLIFERATION DE KERATINOCYTES, EN PARTICULIER LA DERMATITE ATOPIQUE ET LE PSORIASIS
Abstract: front page image
(EN)The present invention further relates to the use of Riluzole in a topical medicament for the treatment and/or prevention of neuronal or brain diseases and/or injuries, as well as topical combination preparations comprising Riluzole and agents effective in treating neuronal or brain diseases and/or injuries.
(FR)La présente invention porte sur l'utilisation du Riluzole, si besoin avec des adjuvants et des additifs appropriés pour la production d'un médicament destiné à être utilisé dans le traitement de maladies caractérisées par l'hyperprolifération des kératinocytes et/ou des lymphocytes T, en particulier le psoriasis et la neurodermatite, l'invention portant également sur des compositions comprenant le Riluzole et sur leurs utilisations.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)